The Photodynamic Therapy Market is predicted to reach US$ 7.28 billion by 2031 from US$ 1.38 billion in 2020, and to grow at a CAGR of ~15.5% between the forecast period 2021 to 2031.
The research report includes specific segments by Products/Type and by Application, by region (country). This study provides information about the sales and revenue of each segment during the historic and forecasted period from 2021 to 2031. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
This report also provides information on the prevalent market dynamics such as market drivers and restraints and future growth opportunities anticipated within the forecast period. The report includes competitive landscape of the top players operating in the market for the base year 2020. The company profiles section of the report studies the position of the major market players based on considerations such as business profile, product/service portfolio, trailing annual revenues, and recent strategies.
Major segmentation covered in this report is as follows:
Product Type (Drugs and Devices), Application (Cancer, Actinic Keratosis (AK), Acne, and Psoriasis), End Users (Hospitals, Cancer Treatment Centers, and Cosmetic & Dermatology Clinics)-
By Region
North America, Europe, Asia Pacific, and the Rest of the World
Major market players covered in this study are
Quantel Medical (Subsidiary of the Lumibird Group), Theralase Technologies Inc., Modulight, Inc., Quest PharmaTech Inc., Biofrontera AG, Galderma, Sun Pharmaceutical Industries Ltd., Bausch & Lomb, SUS Advancing Technology Co., Ltd., and Sagentia, among others.
1. INTRODUCTION
1. Market Ecosystem
2. Timeline Under Consideration
1. Historical Years - 2020
2. Base Year - 2021
3. Forecasted Years - 2022 to 2031
3. Currency Used in the Report
2. RESEARCH METHODOLOGY
1. Research Approach
2. Data Collection Methodology
3. Data Sources
1. Secondary Sources
2. Primary Sources
4. Market Estimation Approach
1. Bottom Up
2. Top Down
5. Market Forecasting Model
6. Limitations and Assumptions
3. PREMIUM INSIGHTS
1. Current Market Trend (COVID-19 Perspective)
2. Key Players & Competitive Positioning (2021)
4. MARKET DYNAMICS
1. Drivers
2. Restraints
3. Opportunities
5. GLOBAL Photodynamic Therapy - ANALYSIS & FORECAST, BY PRODUCT
Product 1, Product 2
6. GLOBAL Photodynamic Therapy - ANALYSIS & FORECAST, BY TYPE
Type 1, Type 2
1. GLOBAL Photodynamic Therapy - ANALYSIS & FORECAST, BY END USER
End User 1, End User 2
2. GLOBAL Photodynamic Therapy - ANALYSIS & FORECAST, BY REGION
North America Photodynamic Therapy
1. North America Photodynamic Therapy , by Country
1. US
2. Canada
1. North America Photodynamic Therapy , by Product
2. North America Photodynamic Therapy , by Type
3. North America Photodynamic Therapy , by Gender
4. North America Photodynamic Therapy , by Sales Channel
3. Europe Photodynamic Therapy
1. Europe Photodynamic Therapy , by Country/Region
1. Germany
2. UK
3. France
4. Rest of Europe
2. Europe Photodynamic Therapy , by Product
3. Europe Photodynamic Therapy , by Type
4. Europe Photodynamic Therapy , by Gender
5. Europe Photodynamic Therapy , by Sales Channel
4. Asia Pacific Photodynamic Therapy
1. Asia Pacific Photodynamic Therapy , by Country/Region
1. China
2. Japan
3. India
4. Rest of Asia Pacific
2. Asia Pacific Photodynamic Therapy , by product
3. Asia Pacific Photodynamic Therapy , by Type
4. Asia Pacific Photodynamic Therapy , by Gender
5. Asia Pacific Photodynamic Therapy , by Sales Channel
5. Rest of the World Photodynamic Therapy
1. Rest of the World Photodynamic Therapy , by Region
1. Latin America
2. Middle East & Africa
2. Rest of the World Photodynamic Therapy , by Product
3. Rest of the World Photodynamic Therapy , by Type
4. Rest of the World Photodynamic Therapy , by Gender
5. Rest of the World Photodynamic Therapy , by Sales Channel
2. COMPANY PROFILES
Company 1, Company 22